Nano-based formulations as an approach for providing a novel identity for organoselenium compounds

Eur J Pharm Biopharm. 2022 Sep:178:69-81. doi: 10.1016/j.ejpb.2022.07.018. Epub 2022 Aug 3.

Abstract

The organoselenium compounds belong to a class of synthetic molecules that displays a remarkable spectrum of promising pharmacological properties. Despite the huge amount of preclinical data that supports a bright outlook for organoselenium compounds, some toxicity issues and physicochemical limitations delay the development of more advanced studies. Currently, several scientific reports demonstrated that the association of nanotechnology has emerged as an alternative to improve solubility and safety issues of these molecules as well as enhance pharmacological properties. Therefore, our main objective was to address studies that reported the development and biological evaluations of nano-based formulations to synthetic organoselenium compounds incorporation by constructing an integrative literature review. The data survey was performed using the Science Direct, PubMed, Web of Science, and SCOPUS online databases, covering studies that were published from January 2011 up to October 2021. In the last decade, there has been an exponential growth in research regarding the incorporation of synthetic organoselenium compounds into distinct nanocarrier systems such as nanocapsules, nanoemulsions, micelles, and others, reinforcing that the association of such molecules and nanotechnology is a promising alliance. The reports investigated many nanosystems containing selenium organic molecules intending oral, intravenous, and cutaneous applications. Besides that, these systems were evaluated in a variety of in vitro techniques and in vivo models, concerning their pharmacological potential, biodistribution profile, and safety. In summary, the findings indicate that the production of nano-based formulations containing organoselenium compounds either improved physicochemical and biological properties or minimize toxicological issues of compounds.

Keywords: Diphenyl diselenide; Ebselen; Nano-based formulations; Nanocapsules; Nanoparticles; Organoselenium compounds; Selenium.

Publication types

  • Review

MeSH terms

  • Nanocapsules* / chemistry
  • Nanotechnology
  • Organoselenium Compounds* / chemistry
  • Organoselenium Compounds* / pharmacology
  • Selenium*
  • Tissue Distribution

Substances

  • Nanocapsules
  • Organoselenium Compounds
  • Selenium